Question: is apalutamide available in canada?
Answer: 16, 2019 /CNW/ - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada, following a Priority Review, has approved ERLEADA® (apalutamide) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).